Original news and analysis on international IP policy
Canada's Parliament has the power to save lives of millions afflicted with HIV around the world if they will act to ease intellectual property-related restrictions on their access to medicines, Canadian civil society groups said today.
Today in Cancun, Mexico, the United Nations climate change conference opened with hopes of finding consensual solutions for the global environmental threat and its consequences. After the disappointing results of last year’s conference in Copenhagen, echoes of uncertainty on the outcome of the Cancun conference are being heard from many sides.
As the end of 2010 nears, bringing with it the end of the otherwise unremarkable international year of biodiversity, the UN Convention on Biological Diversity is calling for countries to ratify the newly agreed protocol on biodiversity access and benefit sharing as soon as it opens for signature in February.
As the first flurries of snow gave Geneva a foretaste of winter, delegates yesterday ended a week of negotiations in the World Intellectual Property Organization committee overseeing implementation of the WIPO Development Agenda. They agreed on some projects and postponed discussions on others until the next session, but remained frozen without agreement on details of the coordination mechanism for Agenda implementation. Numerous corridor discussions and informal meetings did not help the process.
Members of the United Nations World Intellectual Property Organization this week are in discussions on how to ensure that WIPO activities are development-oriented. A particular focus will be the implementation of a Development Agenda coordination mechanism approved at the last session in May. Also new on the table this week is an agenda item on development-related issues and a proposal for a new project on cooperation between developing countries.
Innovation or “jugaad” has always driven the Indian economy. However, the last decade has been witness to an emerging paradigm shift to high-quality value-added innovation, writes industry lawyer Sunita K. Sreedharan.
The US Food and Drug Administration heard from myriad pharmaceutical companies, patient groups, and other stakeholders last week as the agency considers how to create an abbreviated pathway to bring more biologic drugs to market.
"Instead of re-hashing old debates about patents, patients and profits, forward-looking pharmaceutical executives should consider new ways of ensuring that medicines reach all patients who need them," writes John Erickson, one of the researchers who discovered the HIV medicine recently licensed by the National Institutes of Health to the Medicines Patent Pool.
With a standing ovation in the early hours of the morning of Saturday, in Nagoya, Japan, an international instrument aimed at preventing misappropriation of genetic resources was adopted by members of the United Nations Convention on Biological Diversity. The protocol is also intended to ensure that benefits accrued from the use of those genetic resources are shared equitably with the provider country.
A substantive review of a rarely-used amendment to the World Trade Organization intellectual property rules and enforcement trends that may threaten multilateral trade system topped the agenda this week in the Council on Trade-Related Aspects of Intellectual Property Rights (TRIPS).
Daniele Dionisio writes: The current break-through of multinational drug corporations in India couples with the protectionist policies pursued by the US and EU and with India’s obligations as a WTO member. Taken together, these realities mean a heavy threat to India’s freedom as independent provider of lifesaving, affordable and state-of-the-art antiretroviral medicines to the resource-limited countries.
As ministers arrived in Nagoya, Japan, for the high-level segment of the UN Convention on Biological Diversity today, negotiators kept trying to reach consensus on remaining agenda items, such as a strategic plan, or an international legal instrument to prevent biopiracy and ensure the fair and equitable sharing of benefits accrued from the use of genetic resources.